Ahmad Ullah Humza, Abdul Hameed, Muhammad Asad Akbar, Imran Ahmed, Asif Ali, Jibran Bin Yousuf
As a major concern in the healthcare sector, polypharmacy is correlated with an increased risk of potential drug-drug interactions (pDDIs), treatment costs and adverse drug reactions (ADR).
Polypharmacy
hyper-polypharmacy
cardiovascular disease (CVD)
hospitalized patients
co-morbidities